{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T08:16:11Z","timestamp":1776240971649,"version":"3.50.1"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01493","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T05:04:40Z","timestamp":1562043880000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Complement Receptor Type 1 (CR1, CD35), the Inhibitor of BCR-Mediated Human B Cell Activation, Differentially Regulates TLR7, and TLR9 Induced Responses"],"prefix":"10.3389","volume":"10","author":[{"given":"Bernadett","family":"M\u00e1csik-Valent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katinka","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Fazekas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Erdei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/imr.12498","article-title":"The versatile functions of complement C3-derived ligands","volume":"274","author":"Erdei","year":"2016","journal-title":"Immunol Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1126\/science.271.5247.348","article-title":"C3d of complement as a molecular adjuvant: bridging innate and acquired immunity","volume":"271","author":"Dempsey","year":"1996","journal-title":"Science."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.4049\/jimmunol.168.6.2782","article-title":"Complement receptor type 1 (CD35) mediates inhibitory signals in human B lymphocytes","volume":"168","author":"Jozsi","year":"2002","journal-title":"J Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/intimm\/dxs090","article-title":"Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients","volume":"25","author":"Kremlitzka","year":"2013","journal-title":"Int Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5758192","DOI":"10.1155\/2016\/5758192","article-title":"Complement receptor type 1 suppresses human B cell functions in SLE patients","volume":"2016","author":"Kremlitzka","year":"2016","journal-title":"J Immunol Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.imlet.2007.12.016","article-title":"An antibody-based construct carrying DNA-mimotope and targeting CR1(CD35) selectively suppresses human autoreactive B-lymphocytes","volume":"116","author":"Voynova","year":"2008","journal-title":"Immunol Lett."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1002\/eji.201141439","article-title":"Elimination of autoreactive B cells in humanized SCID mouse model of SLE","volume":"41","author":"Kerekov","year":"2011","journal-title":"Eur J Immunol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im1412s109","article-title":"Toll-like receptors","volume":"109","author":"Takeda","year":"2015","journal-title":"Curr Protocols Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/08830185.2017.1380200","article-title":"Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals","volume":"37","author":"Vidya","year":"2018","journal-title":"Int Rev Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1365-2567.2006.02392.x","article-title":"A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation","volume":"118","author":"Mansson","year":"2006","journal-title":"Immunology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.4049\/jimmunol.1502599","article-title":"TLR10 is a negative regulator of both MyD88-dependent and -independent TLR signaling","volume":"196","author":"Jiang","year":"2016","journal-title":"J Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"7202","DOI":"10.1128\/IAI.72.12.7202-7211.2004","article-title":"Toll-like receptor 9 can be expressed at the cell surface of distinct populations of tonsils and human peripheral blood mononuclear cells","volume":"72","author":"Eaton-Bassiri","year":"2004","journal-title":"Infect Immun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jaut.2014.02.005","article-title":"TLR9 expressed on plasma membrane acts as a negative regulator of human B cell response","volume":"51","author":"Guerrier","year":"2014","journal-title":"J Autoimmun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s00018-014-1806-x","article-title":"Syk is indispensable for CpG-induced activation and differentiation of human B cells","volume":"72","author":"Kremlitzka","year":"2015","journal-title":"Cell Molecul Life Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2172-9-39","article-title":"Comparison of human B cell activation by TLR7 and TLR9 agonists","volume":"9","author":"Hanten","year":"2008","journal-title":"BMC Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.4049\/jimmunol.174.7.4043","article-title":"Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN","volume":"174","author":"Bekeredjian-Ding","year":"2005","journal-title":"J Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10875-010-9456-8","article-title":"TLR1\/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors","volume":"31","author":"Agrawal","year":"2011","journal-title":"J Clin Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jaci.2008.09.018","article-title":"Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production","volume":"123","author":"Glaum","year":"2009","journal-title":"J Allergy Clin Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.4049\/jimmunol.1402690","article-title":"TLR7- and TLR9-responsive human B cells share phenotypic and genetic characteristics","volume":"194","author":"Simchoni","year":"2015","journal-title":"J Immunol."},{"key":"B20","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.4049\/jimmunol.159.9.4279","article-title":"Regulation of B cell functions by C3a and C3a(desArg): suppression of TNF-alpha, IL-6, and the polyclonal immune response","volume":"159","author":"Fischer","year":"1997","journal-title":"J Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1182\/blood-2011-01-331462","article-title":"Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c(+) B-cell population is important for the development of autoimmunity","volume":"118","author":"Rubtsov","year":"2011","journal-title":"Blood."},{"key":"B22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0022-1759(91)90290-V","article-title":"A rapid FPLC method for purification of the third component of human and guinea pig complement","volume":"142","author":"Basta","year":"1991","journal-title":"J Immunol Methods."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1172\/JCI118894","article-title":"Activation of human B cells by phosphorothioate oligodeoxynucleotides","volume":"98","author":"Liang","year":"1996","journal-title":"J Clin Invest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1126\/science.1076071","article-title":"Maintenance of serological memory by polyclonal activation of human memory B cells","volume":"298","author":"Bernasconi","year":"2002","journal-title":"Science."},{"key":"B25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/intimm\/dxg058","article-title":"Convergence of CpG DNA- and BCR-mediated signals at the c-Jun N-terminal kinase and NF-kappaB activation pathways: regulation by mitogen-activated protein kinases","volume":"15","author":"Yi","year":"2003","journal-title":"Int Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e96381","DOI":"10.1371\/journal.pone.0096381","article-title":"TGF\u03b2 activated kinase 1 (TAK1) at the crossroad of B cell receptor and Toll-like receptor 9 signaling pathways in human B cells","volume":"9","author":"Szili","year":"2014","journal-title":"PLoS ONE."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1182\/blood-2002-11-3569","article-title":"A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells","volume":"101","author":"Bernasconi","year":"2003","journal-title":"Blood."},{"key":"B28","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/eji.200535744","article-title":"Toll-like receptor stimulation as a third signal required for activation of human naive B cells","volume":"36","author":"Ruprecht","year":"2006","journal-title":"Eur J Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3389\/fimmu.2017.00775","article-title":"TLR7\/TLR9- and B cell receptor-signaling crosstalk: promotion of potentially dangerous B cells","volume":"8","author":"Suthers","year":"2017","journal-title":"Front Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nri3190","article-title":"Integration of B cell responses through Toll-like receptors and antigen receptors","volume":"12","author":"Rawlings","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/ncomms1769","article-title":"BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-kappaB pathway","volume":"3","author":"Pone","year":"2012","journal-title":"Nat Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1182\/blood-2003-08-2972","article-title":"Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help","volume":"103","author":"Poeck","year":"2004","journal-title":"Blood."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e74103","DOI":"10.1371\/journal.pone.0074103","article-title":"Bruton's tyrosine kinase mediates the synergistic signalling between TLR9 and the B cell receptor by regulating calcium and calmodulin","volume":"8","author":"Kenny","year":"2013","journal-title":"PLoS ONE."},{"key":"B34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.immuni.2008.03.019","article-title":"The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens","volume":"28","author":"Chaturvedi","year":"2008","journal-title":"Immunity."},{"key":"B35","doi-asserted-by":"publisher","first-page":"7397","DOI":"10.4049\/jimmunol.179.11.7397","article-title":"Functional outcome of B cell activation by chromatin immune complex engagement of the B cell receptor and TLR9","volume":"179","author":"Busconi","year":"2007","journal-title":"J Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2249.1997.d01-890.x","article-title":"Extrahepatic complement biosynthesis: where, when and why?","volume":"107","author":"Morgan","year":"1997","journal-title":"Clin Exp Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/cei.12952","article-title":"Production of complement components by cells of the immune system","volume":"188","author":"Lubbers","year":"2017","journal-title":"Clin Exp Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1084\/jem.179.5.1725","article-title":"Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling","volume":"179","author":"Kurosaki","year":"1994","journal-title":"J Exp Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.jaci.2012.03.014","article-title":"Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation","volume":"129","author":"Iwata","year":"2012","journal-title":"J Allergy Clin Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1084\/jem.20050630","article-title":"RNA-associated autoantigens activate B cells by combined B cell antigen receptor\/Toll-like receptor 7 engagement","volume":"202","author":"Lau","year":"2005","journal-title":"J Exp Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/416603a","article-title":"Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors","volume":"416","author":"Leadbetter","year":"2002","journal-title":"Nature."},{"key":"B42","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1074-7613(03)00323-6","article-title":"Activation of autoreactive B cells by CpG dsDNA","volume":"19","author":"Viglianti","year":"2003","journal-title":"Immunity."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1182\/blood-2008-10-185421","article-title":"BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation","volume":"113","author":"Eckl-Dorna","year":"2009","journal-title":"Blood."},{"key":"B44","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.4049\/jimmunol.0901941","article-title":"Differential cytokine production and bystander activation of autoreactive B cells in response to CpG-A and CpG-B oligonucleotides","volume":"183","author":"Avalos","year":"2009","journal-title":"J Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.4049\/jimmunol.0900495","article-title":"Antigen receptor signals rescue B cells from TLR tolerance","volume":"183","author":"Poovassery","year":"2009","journal-title":"J Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.celrep.2017.01.050","article-title":"BCR and endosomal TLR signals synergize to increase AID expression and establish central B cell tolerance","volume":"18","author":"Kuraoka","year":"2017","journal-title":"Cell Rep."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01493\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T22:24:08Z","timestamp":1694989448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01493\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2019.01493"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01493","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"article-number":"1493"}}